Arthritis affecting five or more joints simultaneously, where the underlying cause has not been identified or documented with sufficient specificity to assign a more precise code.
Verified May 8, 2026 · 6 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 10
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M13.0.
Source · Editorial brief grounded in 6 cited references ↓
- List each affected joint by name in the clinical note — polyarthritis implies five or more joints; documentation of the specific joints involved supports medical necessity and guards against audit.
- Record the provider's assessment of etiology: if a cause is known (e.g., psoriasis, gout, seronegative inflammatory disease), a more specific code supersedes M13.0 and should be used.
- Capture relevant lab and imaging results (ESR, CRP, RF, anti-CCP, X-ray findings of joint space narrowing or erosions) to substantiate the diagnosis and support surgical medical necessity when applicable.
- If the encounter is for joint replacement, document conservative treatment failure and functional impairment — M13.0 alone without this narrative is a common payer audit trigger.
- Distinguish polyarthritis from monoarthritis in the note; if only one joint is treated at the encounter, consider whether M13.1x- (Monoarthritis, not elsewhere classified) more accurately reflects the presenting problem.
Related CPT procedures
Procedure codes commonly billed with M13.0. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M13.0 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Assigning M13.0 when the record supports a more specific code — inflammatory polyarthropathy (M06.4x), rheumatoid arthritis (M05/M06), or psoriatic arthritis (L40.5-) — leaving specificity on the table and risking payer queries.
- Using M13.0 for osteoarthritis involving multiple joints: the parent category M13 explicitly excludes osteoarthritis (M15–M19); polyosteoarthritis belongs at M15.0–M15.9.
- Treating M13.0 as a catch-all for 'inflammatory arthritis NOS' without querying the provider — ICD-10-CM has distinct codes for inflammatory polyarthropathy (M06.4x) that should be used when the provider documents an inflammatory pattern.
- Failing to append additional codes for underlying conditions or comorbidities that coexist with the polyarthritis diagnosis when they are documented and clinically relevant to the encounter.
Clinical context
Source · Editorial summary grounded in 6 cited references ↓
M13.0 applies when a provider documents polyarthritis — inflammation or arthropathy involving multiple joints — without specifying the etiology, type, or inflammatory mechanism. It belongs to category M13 (Other arthritis), which by definition excludes arthrosis and osteoarthritis (M15–M19). Use M13.0 only after ruling out more specific codes: rheumatoid arthritis (M05–M06), psoriatic arthropathy (L40.5-), gout (M10), reactive arthritis (M02), and other classified arthropathies all carry their own code families and should be assigned when documented.
In the orthopedic setting, M13.0 is a recognized supporting diagnosis for lower extremity major joint replacement. CMS article A56796 explicitly lists M13.0 among ICD-10-CM codes that support medical necessity for hip and knee arthroplasty (CPT 27130, 27447). That said, it is a low-specificity code — payers and Medicare Administrative Contractors may scrutinize claims where M13.0 appears as the sole justification for surgery without corroborating imaging or clinical documentation of joint destruction.
Do not assign M13.0 when the provider documents inflammatory arthritis with a known cause or pattern that maps to a more definitive code. If the note says 'inflammatory polyarthritis' without further specification, query the provider or consult the alphabetic index — M06.4x (Inflammatory polyarthropathy) or M06.9 may apply instead. M13.0 carries no laterality sub-classification; it is a single billable code with no 5th or 6th character extensions.
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01When should I use M13.0 instead of M06.4x (Inflammatory polyarthropathy)?
02Does M13.0 support medical necessity for total knee or hip replacement?
03Can I use M13.0 for osteoarthritis affecting multiple joints?
04Does M13.0 have any laterality or site-specific sub-codes?
05Is M13.0 valid for outpatient encounters where the diagnosis is still uncertain?
06Can M13.0 be coded on the same claim as a more specific arthropathy code?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026, code M13.0
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M13-/M13.0
- 03cms.govhttps://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=56796&ver=26& (CMS Article A56796: Billing and Coding — Lower Extremity Major Joint Replacement)
- 04cms.govhttps://www.cms.gov/files/document/fy-2025-icd-10-cm-coding-guidelines.pdf (ICD-10-CM Official Guidelines FY2025, Section IV.H)
- 05aahks.orghttps://www.aahks.org/wp-content/uploads/2018/08/ICD10-code-list-27130.pdf (AAHKS ICD-10 Code List for 27130)
- 06aapc.comhttps://www.aapc.com/codes/icd-10-codes/M13.0
Mira Scribe
Mira AI Scribe captures the number and names of affected joints, the provider's stated or suspected etiology, relevant lab markers (RF, anti-CCP, ESR, CRP, uric acid), and imaging findings showing joint involvement. This prevents the encounter from being coded to an overly broad NOS code when a more specific arthropathy category is supportable, and avoids audit exposure on joint replacement claims where M13.0 appears without corroborating clinical narrative.
See how Mira captures M13.0 documentation